Enabling the routine use of miRNAs in drug development and clinical diagnostics
MicroRNAs are powerful early disease biomarkers, but their adoption in drug development and diagnostics settings has been limited by instability, isomiR detection complexity with PCR-based methods, and inconsistent results. Our patented Chemistry overcomes these barriers, unleashing the power of miRNA biomarkers.
First Implementation Case: RUO LiverAce™ Kits
Validated assays for early hepatotoxicity testing in drug development and clinical trials.
For Research Use Only
Not for use in diagnostic procedures
RUO LiverAce™ COMBO Kit
Projected regulatory clearance in 2027
Simultaneous quantification of miR-122 and CK18 in a single reaction. Provides biological depth and data integrity.
RUO LiverAce™ SinglePlex Kit
Rapid, PCR-free miR-122 testing. Absolute isomiR resolution for accurate toxicity assessment.
Data-Driven Insights
Overcoming the challenges of miRNA detection of PCR.
RNA Stabilization
isomiR Detection Capability
Early Detection
Transform Your Analytical Capabilities
"Connect with our specialists to purchase kits or to explore technology licensing and custom assays for your miRNA/proteins of interest"
Get in Touch